Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference
March 02 2021 - 8:00AM
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in
exoskeleton technology for medical and industrial use, today
announced that Jack Glenn, Chief Financial Officer, will present at
the H.C. Wainwright Global Life Sciences Conference held on March 9
– 10, 2021.
A company presentation will be available to view
on-demand as of 4:00 AM PT / 7:00 AM ET, Tuesday, March 9, 2021
throughout the entirety of the conference and available on the
investor section of the Company’s website
at www.eksobionics.com, or by clicking here.
About Ekso
Bionics® Ekso Bionics® is a
leading developer of exoskeleton solutions that amplify human
potential by supporting or enhancing strength, endurance and
mobility across medical and industrial applications. Founded in
2005, the Company continues to build upon its industry-leading
expertise to design some of the most cutting-edge, innovative
wearable robots available on the market. Ekso Bionics is the only
exoskeleton company to offer technologies that range from helping
those with paralysis to stand up and walk, to enhancing human
capabilities on job sites across the globe. The Company is
headquartered in the San Francisco Bay Area and is listed on the
Nasdaq Capital Market under the symbol “EKSO.” For more
information, visit: www.eksobionics.com or follow
@EksoBionics on Twitter.
Investor Contact:David
Carey212-867-1768investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Sep 2023 to Sep 2024